<html>
<head>PUBMED IDs for PTGHS</head>
<body bgcolor='#C5F0F2'><h1>PTGHS</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7750125/'>Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients.</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/7644541/'>Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.</a> August 15  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/10958359/'>A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules.</a> August 25  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15256472/'>HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.</a> July 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17607930/'>Monoclonal and recombinant antibodies with T cell receptor-like reactivity.</a> July 5  2007<br></body></html>
